Published in Stroke on June 09, 2005
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Intracerebral haemorrhage: an often neglected medical emergency. Intern Emerg Med (2007) 1.55
Intracerebral haemorrhage, anticoagulation and mechanical heart valves: what should I do next? BMJ Case Rep (2013) 0.95
OTC analgesics and drug interactions: clinical implications. Osteopath Med Prim Care (2008) 0.89
Treatment targets in intracerebral hemorrhage. Neurotherapeutics (2011) 0.89
Prevention strategies for cardioembolic stroke: present and future perspectives. Open Neurol J (2010) 0.88
Assessing bleeding risk in patients taking anticoagulants. J Thromb Thrombolysis (2013) 0.88
Antithrombotic treatment in atrial fibrillation. Heart (2006) 0.84
Educating orally anticoagulated patients in drug safety: a cluster-randomized study in general practice. Dtsch Arztebl Int (2014) 0.83
Stroke prevention with oral anticoagulation in older people with atrial fibrillation - a pragmatic approach. Aging Dis (2012) 0.82
Cerebral microbleeds: a new dilemma in stroke medicine. JRSM Cardiovasc Dis (2012) 0.81
Delayed ipsilateral parenchymal hemorrhage following treatment of intracranial aneurysms with flow diverter. Neuroradiology (2013) 0.81
The H-ATOMIC Criteria for the Etiologic Classification of Patients with Intracerebral Hemorrhage. PLoS One (2016) 0.80
Microbleeds as a predictor of intracerebral haemorrhage and ischaemic stroke after a TIA or minor ischaemic stroke: a cohort study. BMJ Open (2013) 0.79
Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants. Cardiol Ther (2013) 0.79
Warfarin-associated intracerebral hemorrhage. Neurol Sci (2008) 0.78
Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. J Am Heart Assoc (2015) 0.78
Dual antiplatelet therapy can be discontinued at three months after implantation of zotarolimus-eluting stent in patients with coronary artery disease. ISRN Cardiol (2013) 0.77
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options. J Interv Card Electrophysiol (2012) 0.77
Oral anticoagulant-associated intracerebral hemorrhage. J Neurol (2011) 0.77
Fixed Versus Variable Dosing of Prothrombin Complex Concentrate in Vitamin K Antagonist-Related Intracranial Hemorrhage: A Retrospective Analysis. Neurocrit Care (2017) 0.76
Subdural hematomas in pulmonary arterial hypertension patients treated with prostacyclin analogs [corrected]. Pulm Circ (2012) 0.75
The clinical dilemma of treating transient ischaemic attack-like symptoms in patients with coexisting arteriovenous malformation. BMJ Case Rep (2014) 0.75
Non-Vitamin K Antagonist Oral Anticoagulants: New Choices for Patient Management in Atrial Fibrillation. Am J Cardiovasc Drugs (2015) 0.75
A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients. Cardiol Ther (2015) 0.75
Oral Anticoagulant Prescription in Patients With Atrial Fibrillation and a Low Risk of Thromboembolism: Insights From the NCDR PINNACLE Registry. JAMA Intern Med (2015) 0.75
Brain hemorrhage: restarting anticoagulation after intracranial hemorrhage. Nat Rev Neurol (2011) 0.75
Prevalence and clinical characteristics of intracerebral hemorrhages associated with clopidogrel. J Vasc Interv Neurol (2009) 0.75
Reduction of intracerebral hemorrhage in hemodialysis patients after reducing aspirin use: A quality-assurance observational study. PLoS One (2017) 0.75
Use of rivaroxaban in patients with stroke. Neurol Sci (2017) 0.75
Resumption of Anticoagulation After Intracranial Hemorrhage. Curr Treat Options Neurol (2017) 0.75
Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med (2007) 10.87
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med (2012) 5.69
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation (2002) 3.74
Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem (2004) 2.01
Atrial fibrillation, stroke, and acute antithrombotic therapy: analysis of randomized clinical trials. Stroke (2002) 1.58
Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem (2008) 1.55
Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation (2003) 1.52
Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay. Clin Biochem (2012) 1.49
Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47
Lessons from the Stroke Prevention in Atrial Fibrillation trials. Ann Intern Med (2003) 1.41
Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events. Clin Chem (2009) 1.25
Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials. Stroke (2012) 1.23
Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem (2008) 1.23
Cognitive impairment in lacunar strokes: the SPS3 trial. Ann Neurol (2012) 1.16
Warfarin in atrial fibrillation patients with moderate chronic kidney disease. Clin J Am Soc Nephrol (2011) 1.15
Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation (2002) 1.13
Current status of stroke risk stratification in patients with atrial fibrillation. Stroke (2009) 1.13
Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study. Blood Press Monit (2007) 1.12
Neuroprotection trials in Parkinson's disease: systematic review. Mov Disord (2009) 1.09
Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Ann Intern Med (2007) 1.08
Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem (2007) 1.06
Aspirin therapy and risk of subdural hematoma: meta-analysis of randomized clinical trials. J Stroke Cerebrovasc Dis (2013) 0.95
Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey. Clin Chem (2012) 0.92
Clinical-MRI correlations in a multiethnic cohort with recent lacunar stroke: the SPS3 trial. Int J Stroke (2014) 0.91
Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med (2012) 0.89
Sleep apnea and white matter disease in hypertensive patients: a case series. Neurologist (2011) 0.85
Sex, stroke, and atrial fibrillation. Arch Neurol (2012) 0.82
Aspirin dosage and thromboxane synthesis in patients with vascular disease. Pharmacotherapy (2003) 0.81
Cardiac troponin risk stratification based on 99th percentile reference cutoffs in patients with ischemic symptoms suggestive of acute coronary syndrome: influence of estimated glomerular filtration rates. Am J Clin Pathol (2007) 0.81
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations. Clin Chem (2011) 0.80
Use of the bioMérieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chim Acta (2008) 0.80
Electrocardiographic differentiation of early repolarization from subtle anterior ST-segment elevation myocardial infarction. Ann Emerg Med (2012) 0.79
Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values. Am J Clin Pathol (2003) 0.78
The relevance of living supports on antiplatelet adherence and trial participation: the SPS3 trial. Int J Stroke (2014) 0.75
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2003) 0.75
Carotid-artery stenting versus endarterectomy. N Engl J Med (2005) 0.75
Near-bedside whole-blood cardiac troponin I assay for risk assessment of patients with acute coronary syndromes. Clin Chem (2002) 0.75